International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in...

Area of Science:

• Virology
• Oncology
• Public Health

Background:

• Human papillomavirus (HPV) assays exhibit variability in their minimum detection limits.
• Optimizing HPV detection thresholds is crucial for accurate cervical cancer screening.

Purpose of the Study:

• To investigate the analytical detection thresholds of HPV assays.
• To determine thresholds that optimize sensitivity and specificity for cervical screening.

Main Methods:

• Analysis of 100 cervical intraepithelial neoplasia grade 2+ (CIN2+) cases and 200 controls across 10 international laboratories.
• Estimation of cumulative sensitivity and specificity at varying analytical detection thresholds.
• Evaluation of HPV type distribution in invasive cervical cancer (ICC) and HPV-vaccinated cohorts.

Main Results:

• Consensus HPV detection in 99/100 CIN2+ cases and 52/200 controls.
• Identified optimal thresholds: 3 IU/µl (HPV16/18), 25 IU/µl (HPV31/33/35/45/52/58), and 100 GE/µl (HPV 39/51/56/59).
• Achieved 92.00% cumulative specificity and 90.08% ICC-weighted sensitivity with optimized thresholds, outperforming manufacturer-defined thresholds in specificity.

Conclusions:

• This international collaborative study successfully identified HPV analytical detection thresholds that optimize cervical screening performance.
• The findings provide a basis for standardizing HPV assay performance to improve diagnostic accuracy.
• Understanding these thresholds is vital for effective HPV-based cervical cancer prevention strategies.